Genetically modified organisms for production of polyketides
Strains of yeasts are provided containing the genes for the production of cannabinoids from fatty acids. The enzymes that mediate cannabinoid production are localized to the cytosol, peroxisome or different compartments within the secretory pathway (e.g., endoplasmic reticulum, Golgi, vacuole) to ensure efficient production. The engineered microorganisms produce cannabinoids in a controlled fermentation process.
1. A method of producing a polyketide in a peroxisome, the method comprising:
providing a fatty acid to a genetically modified microorganism, wherein the genetically modified microorganism is a yeast or a fungus, wherein the microorganism comprises a biosynthetic enzyme targeted to the peroxisome in the microorganism, wherein the biosynthetic enzyme is capable of catabolizing the fatty acid into the polyketide, wherein the biosynthetgic enzyme is an acyl-CoA oxidase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, beta-ketothiolase, thiolase, acyl-CoA synthase, polyketide synthase, cannabidiolic acid synthase, tetrahydrocannabidiolic acid, olivetolic acid synthase, tetraketide synthase, TKS 1, or TKS 1 p;
culturing the microorganism under conditions sufficient to produce the polyketide in the peroxisome; and
isolating the polyketide.
2. The method of claim 1 , wherein the polyketide is cannabigerolic acid, 49-tetrahydrocannabinolic acid, cannabidiolic acid, cannabichromenic acid, cannabigerovarinic acid, tetrahydrocannabivarin acid, cannabidivarinic acid, or cannabichromevarinic acid.
3. The method of claim 1 , wherein the yeast is from a genus selected from the group consisting of Candida, Arxula, Pichia, Scheffersomyces, Kluyveromyces, Saccharomyces, Yarrowia , or Schizosaccharomyces.
4. The method of claim 1 , wherein the biosynthetic enzyme comprises a peroxisomal targeting sequence.
5. The method of claim 4 , wherein the peroxisomal targeting sequence has a consensus sequence of [S/A/H/C/E/P/Q/V]-[K/R/H/QHL/F] as set forth in SEQ ID NO: 7, or GRRAKL as set forth in SEQ ID NO: 6.
6. The method of claim 1 , wherein the enzyme is removed of its endogenous amino-terminal localization sequence and/or carboxyl-terminal localization sequence.
7. A genetically modified microorganism, wherein the genetically modified microorganism is a yeast or a fungus, comprising a biosynthetic enzyme targeted to a peroxisome in the microorganism, wherein the biosynthetic enzyme is capable of catabolizing a fatty acid into a polyketide, wherein the biosynthetic enzyme is an acyl-CoA oxidase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, beta-ketothiolase, thiolase, acyl-CoA synthase, polyketide synthase, cannabidiolic acid synthase, tetrahydrocannabidiolic acid, olivetolic acid synthase, tetraketide synthase, TKS1, or TKS 1p.
8. The genetically modified microorganism of claim 7 , wherein the yeast is from a genus selected from the group consisting of Candida, Arxula, Pichia, Scheffersomyces, Kluyveromyces, Saccharomyces, Yarrowia , or Schizosaccharomyces.
9. The genetically modified microorganism of claim 7 , wherein the biosynthetic enzyme comprises a peroxisomal targeting sequence.
10. The genetically modified microorganism of claim 9 , wherein the peroxisomal targeting sequence has a consensus sequence of [S/A/H/C/E/P/Q/V]-[K/R/H/Q]-[L/F] as set forth in SEQ ID NO: 7, or GRRAKL as set forth in SEQ ID NO: 6.
11. The genetically modified microorganism of claim 7 , wherein the microorganism is capable of producing in the peroxisome cannabigerolic acid, 49-tetrahydrocannabinolic acid, cannabidiolic acid, cannabichromenic acid, cannabigerovarinic acid, tetrahydrocannabivarin acid, cannabidivarinic acid, or cannabichromevarinic acid when cultured.
12. The genetically modified microorganism of claim 7 , wherein the microorganism is capable of producing in the peroxisome a triacetic lactone (TAL).
13. A genetically modified microorganism, wherein the genetically modified microorganism is a yeast or a fungus, comprising a biosynthetic enzyme targeted to a peroxisome in the microorganism, wherein the biosynthetic enzyme is capable of catabolizing a fatty acid, vegetable oil, or an alkane into a polyketide, wherein the biosynthetic enzyme comprises a peroxisomal targeting sequence having a consensus sequence of [S/A/H/C/E/P/Q/V]-[K/R/H/QHL/F1 as set forth in SEQ ID NO: 7, or GRRAKL as set forth in SEQ ID NO: 6.
14. The genetically modified microorganism of claim 13 , wherein the biosynthetic enzyme is an acyl-CoA oxidase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, beta-ketothiolase, thiolase, acyl-CoA synthase, polyketide synthase, cannabidiolic acid synthase, tetrahydrocannabidiolic acid, olivetolic acid synthase, tetraketide synthase, TKS1, or TKS1p.
15. The method of claim 1 , wherein the microorganism is capable of producing in the peroxisome a triacetic lactone (TAL).
16. The method of claim 1 , wherein the acyl-CoA oxidase comprises the protein sequence as set forth in SEQ ID NO: 10.
17. The method of claim 1 , wherein the polyketide is olivetolic acid or hexanoic acid.
18. The genetically modified microorganism of claim 7 , wherein the acyl-CoA oxidase comprises the protein sequence as set forth in SEQ ID NO: 10.
19. The genetically modified microorganism of claim 7 , wherein the polyketide is olivetolic acid or hexanoic acid.
20. The genetically modified microorganism of claim 7 , wherein the yeast is from a genus of Candida.